• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.53% Nasdaq Up 0.11%

    Esperion Therapeutics, Inc. (ESPR)

    -NasdaqGM
    91.23 Up 6.06(7.12%) 4:00PM EDT
    |After Hours : 91.13 Down 0.10 (0.11%) 4:48PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:85.17
    Open:86.85
    Bid:91.14 x 100
    Ask:92.99 x 200
    1y Target Est:125.90
    Beta:2.340
    Next Earnings Date:10-Aug-15ESPR Earnings announcement
    Day's Range:86.68 - 92.53
    52wk Range:13.90 - 120.96
    Volume:1,673,591
    Avg Vol (3m):811,925
    Market Cap:2.05B
    P/E (ttm):N/A
    EPS (ttm):-2.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ESPRUp 7.12%2.05B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.40
    Quarterly EPS Est (Jun-15) :-0.57
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.61

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and ot... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback